Zhiyi Biotech Initiates Phase III Clinical Trial for SK08 in China

News: The Phase I clinical trial of SK10 was approved by the US Ethics Committee

Zhiyi Biotech Received Clinical Approval from U.S. FDA for SK10 in Chemotherapy-induced Diarrhea

Zhiyi Biotech Raised $45 Million in Series B Funding Round to Accelerate the Clinical Development of LBPs Pipelines

News: The application for the clinical trial of SK08 combined with anti-PD-1 / L1 monoclonal antibodies in treating advanced solid tumors was approved

The application for clinical trial of SK08 combined with immune checkpoint inhibitor in the treatment of advanced solid tumors was accepted

Zhiyi Named the “Future Unicorn” of Guangzhou Innovative Enterprises in 2021

Zhiyi Biotech Raised Nearly CNY100 Million B+ Round of Financing to Accelerate the Development of LBPs Pipeline

ZYBIO ” Live Biotherapeutics Engineering &Technology Research Center of Guangdong Province ” is awarded

Successful Completion of Phase I Clinical Study of SK08

Zhiyi Biotech Closes CNY110 Million B Round for Live Biotherapeutics Development

SK08 Phase I Clinical Trial Officially Enrolled

Approval for Clinical Trials of SK08